Literature DB >> 24293678

Use of pimobendan in feline congenital heart failure.

Shannon Wainberg1.   

Abstract

A 6-month-old domestic shorthair cat was referred for evaluation of sudden lethargy and tachypnea following ovariohysterectomy. Upon failure of improvement with supportive care, a cardiologist identified congenital tricuspid dysplasia with signs of heart failure. Furosemide, enalapril, and pimobendan were used to reduce clinical signs and improve length and quality of life.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24293678      PMCID： PMC3831393     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  9 in total

1.  Effect of oral administration of pimobendan in cats with heart failure.

Authors:  Sonya G Gordon; Ashley B Saunders; Risa M Roland; Randolph L Winter; Lori Drourr; Sarah E Achen; Crystal D Hariu; Ryan C Fries; May M Boggess; Matthew W Miller
Journal:  J Am Vet Med Assoc       Date:  2012-07-01       Impact factor: 1.936

2.  Pharmacokinetics of oral pimobendan in healthy cats.

Authors:  Andrew S Hanzlicek; Ronette Gehring; Butch Kukanich; Kate S Kukanich; Michele Borgarelli; Nicole Smee; Emily E Olson; Marco Margiocco
Journal:  J Vet Cardiol       Date:  2012-10-30       Impact factor: 1.701

3.  Use of pimobendan in 170 cats (2006-2010).

Authors:  John M Macgregor; John E Rush; Nancy J Laste; Rebecca L Malakoff; Suzanne M Cunningham; Natalie Aronow; Daniel J Hall; Justin Williams; Lori L Price
Journal:  J Vet Cardiol       Date:  2011-10-24       Impact factor: 1.701

4.  The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments.

Authors:  R J Solaro; K Fujino; N Sperelakis
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

5.  Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.

Authors:  K Fujino; N Sperelakis; R J Solaro
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

6.  Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.

Authors:  D Brunkhorst; H v der Leyen; W Meyer; R Nigbur; C Schmidt-Schumacher; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

7.  Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone.

Authors:  J C Rüegg; G Pfitzer; D Eubler; C Zeugner
Journal:  Arzneimittelforschung       Date:  1984

8.  Mechanoenergetic effects of pimobendan in canine left ventricles. Comparison with dobutamine.

Authors:  K Hata; Y Goto; S Futaki; Y Ohgoshi; H Yaku; O Kawaguchi; T Takasago; A Saeki; T W Taylor; T Nishioka
Journal:  Circulation       Date:  1992-10       Impact factor: 29.690

Review 9.  A review of the pharmacology and clinical uses of pimobendan.

Authors:  Kimberly L Boyle; Elizabeth Leech
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2012-08
  9 in total
  1 in total

1.  Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.

Authors:  Karsten E Schober; John E Rush; Virginia Luis Fuentes; Tony Glaus; Nuala J Summerfield; Kathy Wright; Linda Lehmkuhl; Gerhard Wess; Margaret P Sayer; Joao Loureiro; John MacGregor; Nicole Mohren
Journal:  J Vet Intern Med       Date:  2021-02-05       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.